Analyst Ratings for Lineage Cell Therapeutics Inc. (LCTX)
LCTX Rating Summary
LCTX Price Target Summary
- Highest: $9.00 (H.C. Wainwright)
- Lowest: $3.00 (Maxim Group)
- Average: $5.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.67 (+206.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/18/2024 | D. Boral Capital | Jason Kolbert | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.86 (1.85) |
115.12% | Details |
| 8/20/2024 | Craig-Hallum » Updated 3/11/2025 |
Albert Lowe | New Coverage | Buy (N/A) |
3.00 (4.00) |
0.88 (1.85) |
110.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
